Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LYCOPODIUM LIMITED Earnings Release 2008

Aug 21, 2008

65278_rns_2008-08-21_42069ca0-cec3-4b7b-8d8d-ca92f1a00790.pdf

Earnings Release

Open in viewer

Opens in your device viewer

==> picture [226 x 51] intentionally omitted <==

Level 5, 1 Adelaide Terrace East Perth, Western Australia 6004 PO Box 6832, East Perth Western Australia 6892 Tel +618 6210 5222 Fax +618 6210 5201 www.lycopodium.com.au

ASX RELEASE

Revenue : $120.5 million, up 15.2% from 2007 result Profit Before Tax : $17.6 million, up 42% from 2007 result Profit After Tax : $12.4 million, up 40.2% from 2007 result Earnings Per Share : 33.0 cents, up 39.8% from 2007 result Total Dividend : 25.0 cents per share, up 42.9% from 2007 result Interim Dividend : 5.0 cents per share Final Dividend : 20.0 cents per share

The Board of Lycopodium is pleased to announce that activities during the 2008 financial year have produced an after tax profit of $12.4 million, up 40.2% from the 2007 result. Revenue grew 15.2% to $120.5 million.

The Board has declared a final dividend of 20.0 cents per share fully franked taking the total dividend to 25.0 cents per share.

Strong demand continued for Lycopodium’s services particularly in the minerals sector throughout the year enabling growth in personnel from 530 to 650. Lycopodium’s expansion continued in Queensland and a further commitment was made during the year to expand the office facilities in Manila, Philippines.

Demand for services continued in iron ore, nickel, gold, copper/cobalt, tungsten/molybdenum, and other commodities in the minerals sector with a number of projects in various phases of development. Further studies and projects were carried out for, amongst others, Rio Tinto, BHP Billiton, Barrick, Newmont and First Quantum Minerals.

The biodiesel plant in Victoria was successfully commissioned and work continued in the chemical, industrial, food and pharmaceutical sectors for Orica, Thales, Yakult, GlaxoSmithKline and Baxter Health Care.

The full effects of the uncertainty within global markets, precipitated by the sub prime crisis within the USA that unfolded during the year, are still to be seen. At this time however, minerals commodity prices remain high in relation to historical trends and the outlook remains generally positive within the sector which continues to provide an environment of high demand for Lycopodium’s services. The level of activity in the biodiesel, manufacturing and general industrial environments within Australia is not as buoyant as the resources sector however, and this market segment continues to remain challenging at this time.

The Directors would like to extend their sincere appreciation to all personnel for their particular skill and effort in contributing towards the continuing success of Lycopodium.

Dividend Entitlements

The final dividend of 20.0 cents per share fully franked will be paid to shareholders on 17 October 2008 with a record date of 1 October 2008.

Further information:

==> picture [27 x 28] intentionally omitted <==

Mark Ward Managing Director Lycopodium Limited T: +61 8 6210 5222

22 August 2008